CDC says flu resistant to antiviral drug
Infection Control Weekly Monitor, December 31, 2008
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
The CDC alerted healthcare professionals earlier this month that a prevalent strain of influenza is resistant to the antiviral drug oseltamivir, also known as Tamiflu. CDC officials said physicians should add another drug or use an alternative to treat such flu cases.
The CDC said although influenza activity is low in the United States so far this flu season, preliminary data from a limited number of states indicate that the prevalence of influenza A (H1N1) virus strains resistant to the antiviral medication oseltamivir is high. When influenza A virus infection or exposure is suspected, healthcare workers are advised to use zanamivir or a combination of oseltamivir and rimantadine as more appropriate options than oseltamivir alone. To read the CDC health advisory, click here.
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
Comments
0 comments on “CDC says flu resistant to antiviral drug ”
Related Products
-
Patient Safety Monitor
As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...
-
Patient Safety Monitor Alert
This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...
-
Infection Control Weekly Monitor
Infection Control Weekly Monitor keeps you up-to-date on what's happening in the world of infection control. Every issue...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched